Axim Biotechnologies Inc (OTCQB:AXIM)

0.39
Delayed Data
As of Dec 10
 -0.04 / -9.30%
Today’s Change
0.36
Today|||52-Week Range
2.50
-48.00%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues8.2K6.2K167.0K17.1K
 
 
 
 
 
Cost of Goods Sold2.3K3.2K1.3K4.4K
 
 
 
 
 
Depreciation And Amortization839.00839.00839.004.0K
 
 
 
 
 
 
Operating ExpensesGross Income5.1K2.2K164.8K8.7K
 
 
 
 
 
General Expenses1.3M938.0K887.9K2.3M
 
 
 
 
 
Research And Development672.7K350.6K354.2K532.7K
 
 
 
 
 
Total Operating Expenses1.3M942.1K890.1K2.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.3M-935.8K-723.1K-2.3M
 
 
 
 
 
Extraordinary Credit0.000.000.0025.0K
 
 
Extraordinary Charge0.00-114.7K-24.8K0.00
 
 
 
Interest Expense On Debt337.6K283.1K231.0K74.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-1.7M-1.3M-978.9K-2.3M
 
 
 
 
 
Net Income-1.7M-1.3M-978.9K-2.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS56.9M57.9M59.6M60.3M
 
 
 
 
 
Shares To Calculate EPS Diluted56.9M57.9M59.6M60.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.03-$0.02-$0.02-$0.04
 
 
 
 
 
EPS Diluted-$0.03-$0.02-$0.02-$0.04